Condition: Cervical Preparation · Sponsor: Montefiore Medical Center
The Investigator team hypothesizes that in a randomized trial comparing mifepristone-alone or misoprostol-alone for cervical preparation for procedural abortions at 12 to 16 weeks in hospital-based care, the proportion of patients who achieve successful cervical dilation will be different between the study groups.
This description comes directly from the study's public registry record.
Laura Fletcher, MD, MPH · 516-587-3297 · lfletcher@montefiore.org
Antoinette Danvers, MD, MSCR, MBA · 718-405-8260 · adanvers@montefiore.org
Always discuss trial participation with your own doctor first.
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06502158